Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Genetic Signatures Gets OK From Australian Authority for 'Superbug' Kit

Genetic Signatures Gets OK From Australian Authority for 'Superbug' Kit

May 15, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Signatures said on Tuesday it has received regulatory approval in that country to market its detection kit for antibiotic-resistant pathogens.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. BD Gets CE-IVD Mark for Point-of-Care Coronavirus Antigen Test

  2. Roche SARS-CoV-2 Lateral Flow Antigen Test Could Meet Significant Demand

    Premium

  3. Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

  4. PerkinElmer Newborn Screening Assay Receives CE-IVD Mark

  5. Oxford Immunotec Gets FDA Clearance for TB Test in Patients Aged Two and Older

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.